DLA Piper advised Iovance, and Latham & Watkins advised the underwriters. Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) announced the pricing of an underwritten public offering of 20,000,000 shares...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz represented Amgen, while Latham & Watkins represented ChemoCentryx in the transaction. Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Sempra Energy in the offering. Sempra Energy closed its underwritten offering of US$750,000,000 aggregate principal amount of 3.300% Notes due 2025 and US$500,000,000...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented San Diego Gas & Electric Company in the offerings. San Diego Gas & Electric Company, an indirect subsidiary of Sempra Energy, closed...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Southern California Gas Company in the offering. Southern California Gas Company, an indirect subsidiary of Sempra Energy, closed on March 14, 2022 its...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Bionomics in the offering. Bionomics Limited, a clinical-stage biopharmaceutical company, has announced the pricing of its initial public offering in the United States...
You must be a Standard 1 Year member to access this content.
